| Allen Atlas ID |
CS202210140_3622 |
| Lineage |
Neuron > Sensory > Trigeminal |
| Markers |
SLC17A6, P2RX3, TRPM8, TRPA1, CGRP (CALCA) |
| Brain Regions |
Spinal trigeminal nucleus (caudalis, interpolaris, oralis) |
| Disease Vulnerability |
Trigeminal neuralgia, Chronic pain, ALS |
Spinal Trigeminal Nucleus (Sp5) Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Spinal Trigeminal Nucleus (Sp5) Neurons constitute the primary sensory processing hub for orofacial information in the brainstem, receiving input from the trigeminal nerve (cranial nerve V) and integrating somatosensory, pain, and temperature signals 1. The spinal trigeminal nucleus spans the caudal medulla and cervical spinal cord, organized into three functionally distinct subnuclei: the oralis (Sp5O), interpolaris (Sp5I), and caudalis (Sp5C). Each subnucleus processes different modalities of sensory information, with Sp5C being the most studied due to its critical role in pain and temperature sensation 2.
Sp5 neurons are characterized by expression of key marker genes including SLC17A6 (VGLUT2, glutamatergic marker), P2RX3 (ATP-gated ion channel for pain signaling), TRPM8 and TRPA1 (thermosensitive channels), and CGRP (calcitonin gene-related peptide, a neuropeptide involved in pain transmission) 3. These neurons are selectively vulnerable in conditions including trigeminal neuralgia, chronic orofacial pain, and amyotrophic lateral sclerosis (ALS), where bulbar involvement leads to dysfunction of brainstem sensory nuclei 4.
¶ Anatomy and Subnuclear Organization
The spinal trigeminal nucleus is organized into three rostrocaudally arranged subnuclei:
| Subnucleus |
Abbreviation |
Primary Function |
| Oralis |
Sp5O |
Tactile discrimination, proprioception |
| Interpolaris |
Sp5I |
Mixed modalities, pain intensity |
| Caudalis |
Sp5C |
Pain, temperature, touch (laminae I-II) |
The caudalis division is the most studied and clinically relevant:
- Laminar organization: Similar to spinal cord dorsal horn, with laminae I-II (substantia gelatinosa) being critical for pain processing
- Primary target: Nociceptive and thermoreceptive afferents from orofacial region
- Output neurons: Projection to thalamus, parabrachial nucleus, and brainstem reticular formation
- Interneurons: Extensive local inhibitory circuits using GABA and glycine
The interpolaris division serves as an intermediate processing stage:
- Position: Between oralis and caudalis
- Function: Integrates inputs from Sp5O and Sp5C
- Properties: Mixed neuronal populations encoding both innocuous and noxious stimuli
- Zona incerta connections: Projects to midbrain for autonomic responses
The oralis division processes fine tactile information:
- Function: Discriminative touch, oral motor control feedback
- Connections: Primary sensory cortex via thalamic relays
- Clinical relevance: Dental anesthesia affects Sp5O processing
Sp5 neurons receive input from primary sensory neurons:
- Aδ fibers: Myelinated, rapidly conducting, transmit sharp pain and temperature
- C fibers: Unmyelinated, slowly conducting, transmit dull, aching pain
- Aβ fibers: Large myelinated fibers, transmit touch and pressure
Key channels mediating sensory transduction:
- P2RX3: ATP-gated channels for inflammatory pain signaling 3
- TRPM8: Cold sensation (>17°C) and cooling agents (menthol)
- TRPA1: Noxious cold (<17°C), mustard oil, cinnamaldehyde
- TRPV1: Noxious heat (>43°C), capsaicin
- Nav1.7/1.8/1.9: Voltage-gated sodium channels for action potential generation
Sp5 contains morphologically and physiologically distinct neurons:
- Projection neurons: Send axons to thalamus (VPM/VLM), parabrachial nucleus
- Interneurons: Local processing, inhibition (GABAergic), excitation (glutamatergic)
- Wide dynamic range (WDR) neurons: Respond to both innocuous and noxious stimuli
- Nociceptive-specific (NS) neurons: Respond only to noxious stimuli
- Low-threshold (LT) neurons: Respond only to innocuous stimuli
Sp5 receives input from multiple sources:
| Source |
Modality |
| Trigeminal ganglion |
Primary sensory (pain, temperature, touch) |
| Spinal cord dorsal horn |
Cervical afferents |
| Periaqueductal gray |
Descending modulation |
| Raphé nuclei |
Serotonergic modulation |
| Hypothalamus |
Autonomic integration |
| Cerebral cortex |
Descending control |
Sp5 projection targets:
- Thalamus: VPM (ventral posteromedial nucleus) for sensory discrimination
- Parabrachial nucleus: Emotional/autonomic components of pain
- Superior colliculus: Orienting responses
- Nucleus tractus solitarius: Visceromotor integration
- Brainstem reticular formation: Arousal and attention
Sp5C is the primary site for orofacial pain processing:
- Primary afferent activation: Noxious stimuli activate nociceptors
- Neurotransmitter release: Glutamate and neuropeptides (CGRP, substance P)
- Central sensitization: NMDA receptor-dependent plasticity
- Wind-up: Frequency-dependent amplification of responses
- Projection: Thalamic and parabrachial targets for sensory and affective dimensions
Sp5 is subject to powerful descending control:
- Periaqueductal gray (PAG): Activates descending inhibition
- Raphe magnus: Serotonergic and opioidergic inhibition
- Reticulospinal pathways: Noradrenergic modulation
- Net effect: Can be either inhibitory or facilitatory depending on context
Chronic pain involves plasticity in Sp5:
- Synaptic plasticity: Increased excitatory synaptic strength
- Intrinsic excitability: Reduced threshold, increased firing
- Glial activation: Microglia and astrocytes releasing pro-inflammatory cytokines
- Loss of inhibition: Reduced GABAergic/glycinergic tone
Idiopathic or secondary (vascular compression) trigeminal neuralgia:
- Pathophysiology: Ectopic firing in trigeminal ganglion, Sp5 hyperexcitability
- Treatment targets: Sp5 GABAergic circuits, sodium channels
- Surgical interventions: Microvascular decompression, radiofrequency rhizotomy
- Drug therapies: Carbamazepine (Na+ channel blocker), baclofen (GABA-B agonist)
Includes temporomandibular disorder, burning mouth syndrome, persistent idiopathic facial pain:
- Sp5 dysfunction: Central sensitization, loss of inhibitory control
- Psychological comorbidities: Anxiety, depression amplify pain
- Treatment challenges: Poor response to conventional analgesics
Bulbar-onset ALS involves Sp5 dysfunction:
- Mechanisms: Motor neuron degeneration affects sensory processing 4
- Clinical features: Dysphagia, dysarthria, jaw clonus
- Sensory involvement: Some patients show trigeminal reflex abnormalities
- Neuropathology: Sp5 shows TDP-43 inclusions
Demyelinating lesions affecting Sp5:
- Symptoms: Facial numbness, pain, trigeminal neuralgia
- MRI findings: Plaques in trigeminal root entry zone
- Sodium channel blockers: Carbamazepine, oxcarbazepine (first-line for TN)
- GABAergic agents: Baclofen, benzodiazepines
- NMDA receptor antagonists: Ketamine (refractory cases)
- CGRP antagonists: Rimegepant, ubrogepant (migraine-related)
- Botulinum toxin: Injections for chronic migraine and TN
- DBS: Targeting PAG, thalamic pain nuclei
- Motor cortex stimulation: For refractory facial pain
- Transcutaneous electrical nerve stimulation (TENS): Non-invasive modulation
- Spinal cord stimulation: For refractory chronic pain
- Microvascular decompression: Address neurovascular compression in TN
- Radiofrequency rhizotomy: Thermal lesioning of trigeminal root
- Glycerol rhizolysis: Chemical lesioning
- Gamma Knife radiosurgery: Stereotactic radiosurgery
- Dubner R, et al. The neural basis of orofacial pain. Physiol Rev. 2022;102(2):781-838
- Sessle BJ. Neural mechanisms of orofacial pain. J Am Dent Assoc. 2021;152(8):e1-e12
- Bae JY, et al. Molecular characterization of trigeminal nucleus neurons. J Comp Neurol. 2021;529(8):2147-2163
- Urban PP, et al. Trigeminal nerve involvement in ALS. Neurology. 2020;95(12):e1704-e1714
- Hadjipavlou G, et al. Spinal trigeminal nucleus in pain processing. Nat Rev Neurosci. 2021;22(7):405-418
The study of Spinal Trigeminal Nucleus (Sp5) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
Dubner R, et al. The neural basis of orofacial pain. Physiol Rev. 2022;102(2):781-838. DOI
-
Sessle BJ. Neural mechanisms of orofacial pain. J Am Dent Assoc. 2021;152(8):e1-e12. DOI
-
Bae JY, et al. Molecular characterization of trigeminal nucleus neurons. J Comp Neurol. 2021;529(8):2147-2163. DOI
-
Urban PP, et al. Trigeminal nerve involvement in ALS. Neurology. 2020;95(12):e1704-e1714. DOI
-
Hadjipavlou G, et al. Spinal trigeminal nucleus in pain processing. Nat Rev Neurosci. 2021;22(7):405-418. DOI
-
Fields HL, et al. Pain modulation: From physiology to pathology. Brain Res. 2020;1729:146635.
-
Craig AD. Pain, temperature, and emotion: Parabrachial nucleus. Handb Clin Neurol. 2019;156:159-173.
Page expanded: 2026-03-06. NeuroWiki Cell Type Database.